Summary of findings: levofloxacin for inhalation solution vs tobramycin
Survival · adults and children aged over 12 with CF and P aeruginosa
The review found no eligible studies for this question.
1 finding from 1 review
- Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found